Department of Medicine
Hematology/Oncology |
| Hematology/Oncology |
| Lung cancer treatment |
| Boston: Massachusetts General Hospital |
MD,Harvard Medical School
PhD,Harvard University |
| Medical Oncology, American Board of Internal Medicine |
| Female |
| Adult |
| Yes |
| View list » Aetna Health Inc.
AllWays Health (NHP) - ACD
AllWays Health (NHP) - PBO
Beech Street
Blue Cross Blue Shield - Blue Care 65
Blue Cross Blue Shield - Indemnity
Blue Cross Blue Shield - Managed Care
Blue Cross Blue Shield - Partners Plus
BMC HealthNet Mass Health MCO/ACO
Cigna (PAL #'s)
Commonwealth Care Alliance
Fallon Community HealthCare
Great-West Healthcare (formally One Health Plan)
Harvard Pilgrim Health Plan - ACD
Harvard Pilgrim Health Plan - PBO
Health Care Value Management (HCVM)
Humana/Choice Care PPO
MassHealth
Medicare
Medicare - ACD
OSW - Maine
OSW - New Hampshire
OSW - Rhode Island
OSW - Vermont
Private Health Care Systems (PHCS)
Senior Whole Health
TriCare
Tufts Health Plan
Unicare
United Healthcare (non-HMO) - ACD
United Healthcare (non-HMO) - PBO
Well Sense Pediatrics « Hide list |
Alice T. Shaw, MD, PhD, is an attending physician in the Center for Thoracic Cancers at Massachusetts General Hospital and an associate professor of medicine at Harvard Medical School.
In addition to caring for patients with lung cancer, Dr. Shaw also performs clinical and translational research.
Dr. Shaw's major research interests include studying anaplastic lymphoma kinase (ALK) and ROS1 rearrangements in non-small cell lung carcinoma (NSCLC).
She is also studying how lung cancers develop resistance to targeted therapies, and this work has led to a number of novel treatment strategies to overcome resistance in the clinic.
Dr Shaw has been awarded a number of research grants, including grants from the Damon Runyon Cancer Research Foundation, the Burroughs Welcome Fund, the V Foundation for Cancer Research, Uniting Against Lung Cancer, the National Foundation for Cancer Research, and the NIH/NCI.